We regret to advise that the Detect program is coming to a close.

While it is disappointing that this sponsored program is ending, we are proud that our sponsorship of Detect Cardiomyopathy and Arrhythmia and Detect Muscular Dystrophy has achieved some significant outcomes with over 880 patients tested via the services since inception.

Invitae will continue to process no-charge Detect Cardiomyopathy and Arrhythmia and Detect Muscular Dystrophy genetic panels for specimens received in Sydney by September 9, 2022. Please allow sufficient time for courier delivery. For enquiries regarding the Detect program, please contact Invitae support - globalsupport@invitae.com.

As an industry leader in the delivery of life-saving medicines for patients living with rare, often difficult-to-diagnose genetic conditions, we will continue to support healthcare practitioners with medical education and no-cost diagnostic testing for MPS, Gaucher, ASMD, Fabry and Pompe disease.

If you wish to speak to a Sanofi representative, please contact medinfo.australia@sanofi.com.

Thank you.

  • Detect Cardiomyopathy and Arrhythmia:
    The Invitae Cardiomyopathy and Arrhythmia Comprehensive Panel tests up to 168 genes associated with inherited arrhythmia and cardiomyopathy conditions.
    Login/Register to learn more

  • Detect Muscular Dystrophy:
    The Invitae Detect genetic testing program offers six panel options that test for variants in genes associated with muscular dystrophies.
    Login/Register to learn more

LOGIN/REGISTER for more information

Discover full details about Detect genetic panel testing programs, including how to order a kit.